*Gastroenterology Department, 3iHP, University Hospital Estaing
†Microbes, Intestine, Inflammation and Susceptibility of the Host, UMR 1071 Inserm/Clermont Auvergne University
‡Biochemistry Laboratory, University Hospital G. Montpied
§Biostatistics Unit-DRCI, GM—Clermont-Ferrand University and Medical Center, Clermont-Ferrand, France
A.B., E.V., R.M.-Q., M.G.: analysis and interpretation of data. A.B., E.V., M.G., N.B., G.B.: study concept and design. A.B., E.V., R.M.-Q., M.G.: acquisition of data. D.B.: acquisition of data (biochemistry). A.B.: drafting of the manuscript. E.V., R.M.-Q., M.G., D.B., F.G., N.B., G.B.: critical revision of the manuscript for important intellectual content. B.P.: statistical analysis.
A.B. and E.V. contributed equally.
The authors declare that they have nothing to disclose.
Address correspondence to: Anthony Buisson, MD, PhD, Gastroenterology Department, University Hospital Estaing, 1 place Aubrac, 63100 Clermont-Ferrand; Emilie Vazeille, PhD, Microbes, Intestine, Inflammation and Susceptibility of the Host, UMR 1071 Inserm/Université d’Auvergne; USC-INRA 2018, CBRV, 28 place Henri Dunant, 63000 Clermont-Ferrand, France (e-mail: [email protected]; [email protected]).
